Mindset Pharma Inc. (MSSTF)
Mindset Pharma Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.54, down 0.37% on the session, giving a market capitalisation of $54.5M. On trailing twelve-month figures it carries a trailing P/E of -4.11, a net margin of -425.2%. Its beta of -0.10 implies it has historically moved less than the broad market.
Mindset Pharma Inc., headquartered in Toronto, Canada, specializes in researching, developing, and commercializing psychedelic therapeutics. These innovative treatments are designed to address neurological and psychiatric conditions for patients in Canada. A primary focus for the company is the ongoing development of MSP-1014, an investigational psychedelic compound.
Mindset Pharma Inc. is most often compared with the following Healthcare names: